Atlas Trials

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Clinical trial NCT02103894 · COMPLETED

Trial details

NCT number
NCT02103894
Sponsor
Molecular NeuroImaging
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease (AD)Parkinson's Disease (PD)Chronic Traumatic Encephalopathy (CTE)Progressive Supranuclear Palsy (PSP)Frontal Temporal Dementia (FTD)Pick's DiseaseTauopathies
Start date
2014-02-01
Primary completion
2016-08-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.